>> Was a buyback mentioned <<
It's in the OTC disclosure:
On February 22, 2019, the Company announced that its Board of Directors has approved a 750 million share buyback, as part of its previously announced share buyback program.
The goal of the share buyback program is to reduce the total outstanding shares of common stock by up to 80%. Under the buyback program, NSAV is authorized to repurchase shares through open market purchases, privately negotiated transactions, block purchases, fixed price tender offers, or otherwise, in accordance with applicable federal securities laws.
The Company will begin Phase 1 of its share buyback program through privately negotiated transactions, which will commence immediately, with an initial amount of 250 million shares.
The Company is presently in negotiations with several large NSAV shareholders and hopes to repurchase shares in the near future.At the time of this filing, no NSAV shareholders have expressed interest selling their shares of common stock back to the Company in privately negotiated transactions.
The Company has also not repurchased any of its shares of common stock through open market purchases due to the lack of available cash and not being current on its filings with OTC Markets. At thetime of this filing, the Company has not repurchased any shares of its common stock from the proposed share buyback program. The Company is uncertain as to if and when it will be able to repurchase shares of its common stock.